nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—BCHE—Irinotecan—pancreatic cancer	0.721	1	CbGbCtD
Terbutaline—Clenbuterol—TNF—pancreatic cancer	0.00694	0.704	CrCbGaD
Terbutaline—Cramp muscle—Tamoxifen—pancreatic cancer	0.00507	0.0206	CcSEcCtD
Terbutaline—Chest discomfort—Docetaxel—pancreatic cancer	0.00428	0.0173	CcSEcCtD
Terbutaline—Sweating—Tamoxifen—pancreatic cancer	0.00416	0.0169	CcSEcCtD
Terbutaline—Flushing—Tamoxifen—pancreatic cancer	0.00362	0.0147	CcSEcCtD
Terbutaline—Cramp muscle—Irinotecan—pancreatic cancer	0.00358	0.0145	CcSEcCtD
Terbutaline—Muscle spasms—Tamoxifen—pancreatic cancer	0.00326	0.0132	CcSEcCtD
Terbutaline—Injection site pain—Epirubicin—pancreatic cancer	0.00313	0.0127	CcSEcCtD
Terbutaline—Flushing—Sunitinib—pancreatic cancer	0.0031	0.0126	CcSEcCtD
Terbutaline—Sweating—Irinotecan—pancreatic cancer	0.00294	0.0119	CcSEcCtD
Terbutaline—Epinephrine—TNF—pancreatic cancer	0.00292	0.296	CrCbGaD
Terbutaline—Injection site pain—Doxorubicin—pancreatic cancer	0.00289	0.0117	CcSEcCtD
Terbutaline—Chest pain—Tamoxifen—pancreatic cancer	0.00289	0.0117	CcSEcCtD
Terbutaline—Anxiety—Tamoxifen—pancreatic cancer	0.00288	0.0117	CcSEcCtD
Terbutaline—Sweating—Gemcitabine—pancreatic cancer	0.00286	0.0116	CcSEcCtD
Terbutaline—Chest pain—Erlotinib—pancreatic cancer	0.00286	0.0116	CcSEcCtD
Terbutaline—Anxiety—Erlotinib—pancreatic cancer	0.00285	0.0115	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Epirubicin—pancreatic cancer	0.00283	0.0115	CcSEcCtD
Terbutaline—Dry mouth—Tamoxifen—pancreatic cancer	0.00282	0.0115	CcSEcCtD
Terbutaline—Muscle spasms—Sunitinib—pancreatic cancer	0.00279	0.0113	CcSEcCtD
Terbutaline—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00268	0.0109	CcSEcCtD
Terbutaline—Ventricular extrasystoles—Doxorubicin—pancreatic cancer	0.00261	0.0106	CcSEcCtD
Terbutaline—Flushing—Irinotecan—pancreatic cancer	0.00255	0.0103	CcSEcCtD
Terbutaline—Insomnia—Tamoxifen—pancreatic cancer	0.0025	0.0102	CcSEcCtD
Terbutaline—Paraesthesia—Tamoxifen—pancreatic cancer	0.00249	0.0101	CcSEcCtD
Terbutaline—Insomnia—Erlotinib—pancreatic cancer	0.00248	0.01	CcSEcCtD
Terbutaline—Cramp muscle—Docetaxel—pancreatic cancer	0.00247	0.01	CcSEcCtD
Terbutaline—Chest pain—Sunitinib—pancreatic cancer	0.00247	0.01	CcSEcCtD
Terbutaline—Dyspnoea—Tamoxifen—pancreatic cancer	0.00247	0.01	CcSEcCtD
Terbutaline—Dyspnoea—Erlotinib—pancreatic cancer	0.00244	0.0099	CcSEcCtD
Terbutaline—Dry mouth—Sunitinib—pancreatic cancer	0.00242	0.00981	CcSEcCtD
Terbutaline—Muscle spasms—Irinotecan—pancreatic cancer	0.0023	0.00933	CcSEcCtD
Terbutaline—Hypertonia—Epirubicin—pancreatic cancer	0.00224	0.00907	CcSEcCtD
Terbutaline—BCHE—Synthesis, secretion, and deacylation of Ghrelin—PCSK1—pancreatic cancer	0.00218	0.0978	CbGpPWpGaD
Terbutaline—Insomnia—Sunitinib—pancreatic cancer	0.00214	0.0087	CcSEcCtD
Terbutaline—Paraesthesia—Sunitinib—pancreatic cancer	0.00213	0.00863	CcSEcCtD
Terbutaline—Dyspnoea—Sunitinib—pancreatic cancer	0.00211	0.00857	CcSEcCtD
Terbutaline—Hypertonia—Doxorubicin—pancreatic cancer	0.00207	0.00839	CcSEcCtD
Terbutaline—Asthenia—Tamoxifen—pancreatic cancer	0.00199	0.00805	CcSEcCtD
Terbutaline—Chest pain—Gemcitabine—pancreatic cancer	0.00198	0.00805	CcSEcCtD
Terbutaline—Asthenia—Erlotinib—pancreatic cancer	0.00197	0.00797	CcSEcCtD
Terbutaline—Chest pain—Fluorouracil—pancreatic cancer	0.00195	0.00791	CcSEcCtD
Terbutaline—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00189	0.00766	CcSEcCtD
Terbutaline—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00184	0.00746	CcSEcCtD
Terbutaline—Dizziness—Tamoxifen—pancreatic cancer	0.00183	0.00742	CcSEcCtD
Terbutaline—Tachycardia—Fluorouracil—pancreatic cancer	0.00183	0.0074	CcSEcCtD
Terbutaline—Dizziness—Erlotinib—pancreatic cancer	0.00181	0.00734	CcSEcCtD
Terbutaline—Insomnia—Irinotecan—pancreatic cancer	0.00177	0.00716	CcSEcCtD
Terbutaline—Flushing—Docetaxel—pancreatic cancer	0.00176	0.00715	CcSEcCtD
Terbutaline—Vomiting—Tamoxifen—pancreatic cancer	0.00176	0.00714	CcSEcCtD
Terbutaline—Paraesthesia—Irinotecan—pancreatic cancer	0.00175	0.00711	CcSEcCtD
Terbutaline—Rash—Tamoxifen—pancreatic cancer	0.00175	0.00708	CcSEcCtD
Terbutaline—Dermatitis—Tamoxifen—pancreatic cancer	0.00174	0.00707	CcSEcCtD
Terbutaline—Vomiting—Erlotinib—pancreatic cancer	0.00174	0.00706	CcSEcCtD
Terbutaline—Dyspnoea—Irinotecan—pancreatic cancer	0.00174	0.00706	CcSEcCtD
Terbutaline—Somnolence—Irinotecan—pancreatic cancer	0.00174	0.00704	CcSEcCtD
Terbutaline—Headache—Tamoxifen—pancreatic cancer	0.00173	0.00703	CcSEcCtD
Terbutaline—Rash—Erlotinib—pancreatic cancer	0.00173	0.007	CcSEcCtD
Terbutaline—Dermatitis—Erlotinib—pancreatic cancer	0.00173	0.007	CcSEcCtD
Terbutaline—Insomnia—Gemcitabine—pancreatic cancer	0.00172	0.00698	CcSEcCtD
Terbutaline—Headache—Erlotinib—pancreatic cancer	0.00172	0.00696	CcSEcCtD
Terbutaline—Paraesthesia—Gemcitabine—pancreatic cancer	0.00171	0.00693	CcSEcCtD
Terbutaline—Asthenia—Sunitinib—pancreatic cancer	0.0017	0.0069	CcSEcCtD
Terbutaline—Dyspnoea—Gemcitabine—pancreatic cancer	0.0017	0.00688	CcSEcCtD
Terbutaline—Insomnia—Fluorouracil—pancreatic cancer	0.00169	0.00686	CcSEcCtD
Terbutaline—Somnolence—Gemcitabine—pancreatic cancer	0.00169	0.00686	CcSEcCtD
Terbutaline—Paraesthesia—Fluorouracil—pancreatic cancer	0.00168	0.00681	CcSEcCtD
Terbutaline—Dyspnoea—Fluorouracil—pancreatic cancer	0.00167	0.00676	CcSEcCtD
Terbutaline—Somnolence—Fluorouracil—pancreatic cancer	0.00166	0.00674	CcSEcCtD
Terbutaline—Nausea—Tamoxifen—pancreatic cancer	0.00164	0.00667	CcSEcCtD
Terbutaline—Nausea—Erlotinib—pancreatic cancer	0.00163	0.0066	CcSEcCtD
Terbutaline—Muscle spasms—Docetaxel—pancreatic cancer	0.00159	0.00645	CcSEcCtD
Terbutaline—Dizziness—Sunitinib—pancreatic cancer	0.00157	0.00636	CcSEcCtD
Terbutaline—Vomiting—Sunitinib—pancreatic cancer	0.00151	0.00611	CcSEcCtD
Terbutaline—Rash—Sunitinib—pancreatic cancer	0.00149	0.00606	CcSEcCtD
Terbutaline—Dermatitis—Sunitinib—pancreatic cancer	0.00149	0.00606	CcSEcCtD
Terbutaline—Headache—Sunitinib—pancreatic cancer	0.00149	0.00602	CcSEcCtD
Terbutaline—Palpitations—Docetaxel—pancreatic cancer	0.00146	0.00593	CcSEcCtD
Terbutaline—Drowsiness—Epirubicin—pancreatic cancer	0.00143	0.00579	CcSEcCtD
Terbutaline—Chest pain—Docetaxel—pancreatic cancer	0.00141	0.00571	CcSEcCtD
Terbutaline—Nausea—Sunitinib—pancreatic cancer	0.00141	0.00571	CcSEcCtD
Terbutaline—Asthenia—Irinotecan—pancreatic cancer	0.0014	0.00568	CcSEcCtD
Terbutaline—Dry mouth—Docetaxel—pancreatic cancer	0.00138	0.00559	CcSEcCtD
Terbutaline—Sweating—Epirubicin—pancreatic cancer	0.00137	0.00555	CcSEcCtD
Terbutaline—Asthenia—Gemcitabine—pancreatic cancer	0.00137	0.00553	CcSEcCtD
Terbutaline—Drowsiness—Doxorubicin—pancreatic cancer	0.00132	0.00536	CcSEcCtD
Terbutaline—Tachycardia—Docetaxel—pancreatic cancer	0.00132	0.00534	CcSEcCtD
Terbutaline—Dizziness—Irinotecan—pancreatic cancer	0.00129	0.00524	CcSEcCtD
Terbutaline—Sweating—Doxorubicin—pancreatic cancer	0.00127	0.00514	CcSEcCtD
Terbutaline—Vomiting—Irinotecan—pancreatic cancer	0.00124	0.00504	CcSEcCtD
Terbutaline—Dizziness—Fluorouracil—pancreatic cancer	0.00124	0.00502	CcSEcCtD
Terbutaline—Rash—Irinotecan—pancreatic cancer	0.00123	0.00499	CcSEcCtD
Terbutaline—Dermatitis—Irinotecan—pancreatic cancer	0.00123	0.00499	CcSEcCtD
Terbutaline—Headache—Irinotecan—pancreatic cancer	0.00122	0.00496	CcSEcCtD
Terbutaline—Insomnia—Docetaxel—pancreatic cancer	0.00122	0.00495	CcSEcCtD
Terbutaline—Paraesthesia—Docetaxel—pancreatic cancer	0.00121	0.00492	CcSEcCtD
Terbutaline—Vomiting—Gemcitabine—pancreatic cancer	0.00121	0.0049	CcSEcCtD
Terbutaline—Dyspnoea—Docetaxel—pancreatic cancer	0.0012	0.00488	CcSEcCtD
Terbutaline—Somnolence—Docetaxel—pancreatic cancer	0.0012	0.00487	CcSEcCtD
Terbutaline—Rash—Gemcitabine—pancreatic cancer	0.0012	0.00486	CcSEcCtD
Terbutaline—Dermatitis—Gemcitabine—pancreatic cancer	0.0012	0.00486	CcSEcCtD
Terbutaline—Headache—Gemcitabine—pancreatic cancer	0.00119	0.00483	CcSEcCtD
Terbutaline—Flushing—Epirubicin—pancreatic cancer	0.00119	0.00482	CcSEcCtD
Terbutaline—Vomiting—Fluorouracil—pancreatic cancer	0.00119	0.00482	CcSEcCtD
Terbutaline—Rash—Fluorouracil—pancreatic cancer	0.00118	0.00478	CcSEcCtD
Terbutaline—Dermatitis—Fluorouracil—pancreatic cancer	0.00118	0.00478	CcSEcCtD
Terbutaline—Headache—Fluorouracil—pancreatic cancer	0.00117	0.00475	CcSEcCtD
Terbutaline—Nausea—Irinotecan—pancreatic cancer	0.00116	0.0047	CcSEcCtD
Terbutaline—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GCG—pancreatic cancer	0.00114	0.0514	CbGpPWpGaD
Terbutaline—Nausea—Gemcitabine—pancreatic cancer	0.00113	0.00458	CcSEcCtD
Terbutaline—Nausea—Fluorouracil—pancreatic cancer	0.00111	0.00451	CcSEcCtD
Terbutaline—Flushing—Doxorubicin—pancreatic cancer	0.0011	0.00446	CcSEcCtD
Terbutaline—Tension—Epirubicin—pancreatic cancer	0.00109	0.00444	CcSEcCtD
Terbutaline—Nervousness—Epirubicin—pancreatic cancer	0.00108	0.00439	CcSEcCtD
Terbutaline—Muscle spasms—Epirubicin—pancreatic cancer	0.00107	0.00435	CcSEcCtD
Terbutaline—Tension—Doxorubicin—pancreatic cancer	0.00101	0.00411	CcSEcCtD
Terbutaline—Nervousness—Doxorubicin—pancreatic cancer	0.001	0.00407	CcSEcCtD
Terbutaline—Muscle spasms—Doxorubicin—pancreatic cancer	0.000993	0.00402	CcSEcCtD
Terbutaline—Palpitations—Epirubicin—pancreatic cancer	0.000986	0.004	CcSEcCtD
Terbutaline—Asthenia—Docetaxel—pancreatic cancer	0.000969	0.00393	CcSEcCtD
Terbutaline—Chest pain—Epirubicin—pancreatic cancer	0.00095	0.00385	CcSEcCtD
Terbutaline—Anxiety—Epirubicin—pancreatic cancer	0.000947	0.00384	CcSEcCtD
Terbutaline—Dry mouth—Epirubicin—pancreatic cancer	0.000929	0.00377	CcSEcCtD
Terbutaline—Palpitations—Doxorubicin—pancreatic cancer	0.000912	0.0037	CcSEcCtD
Terbutaline—Dizziness—Docetaxel—pancreatic cancer	0.000893	0.00362	CcSEcCtD
Terbutaline—Tachycardia—Epirubicin—pancreatic cancer	0.000889	0.0036	CcSEcCtD
Terbutaline—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00088	0.00357	CcSEcCtD
Terbutaline—Chest pain—Doxorubicin—pancreatic cancer	0.000879	0.00356	CcSEcCtD
Terbutaline—Anxiety—Doxorubicin—pancreatic cancer	0.000876	0.00355	CcSEcCtD
Terbutaline—Dry mouth—Doxorubicin—pancreatic cancer	0.00086	0.00349	CcSEcCtD
Terbutaline—Vomiting—Docetaxel—pancreatic cancer	0.000858	0.00348	CcSEcCtD
Terbutaline—Rash—Docetaxel—pancreatic cancer	0.000851	0.00345	CcSEcCtD
Terbutaline—Dermatitis—Docetaxel—pancreatic cancer	0.00085	0.00345	CcSEcCtD
Terbutaline—Headache—Docetaxel—pancreatic cancer	0.000846	0.00343	CcSEcCtD
Terbutaline—Insomnia—Epirubicin—pancreatic cancer	0.000824	0.00334	CcSEcCtD
Terbutaline—Tachycardia—Doxorubicin—pancreatic cancer	0.000822	0.00333	CcSEcCtD
Terbutaline—Paraesthesia—Epirubicin—pancreatic cancer	0.000818	0.00332	CcSEcCtD
Terbutaline—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000815	0.0033	CcSEcCtD
Terbutaline—Dyspnoea—Epirubicin—pancreatic cancer	0.000812	0.00329	CcSEcCtD
Terbutaline—Somnolence—Epirubicin—pancreatic cancer	0.00081	0.00328	CcSEcCtD
Terbutaline—Nausea—Docetaxel—pancreatic cancer	0.000802	0.00325	CcSEcCtD
Terbutaline—Insomnia—Doxorubicin—pancreatic cancer	0.000762	0.00309	CcSEcCtD
Terbutaline—Paraesthesia—Doxorubicin—pancreatic cancer	0.000757	0.00307	CcSEcCtD
Terbutaline—Dyspnoea—Doxorubicin—pancreatic cancer	0.000751	0.00305	CcSEcCtD
Terbutaline—Somnolence—Doxorubicin—pancreatic cancer	0.000749	0.00304	CcSEcCtD
Terbutaline—Asthenia—Epirubicin—pancreatic cancer	0.000653	0.00265	CcSEcCtD
Terbutaline—Asthenia—Doxorubicin—pancreatic cancer	0.000605	0.00245	CcSEcCtD
Terbutaline—Dizziness—Epirubicin—pancreatic cancer	0.000602	0.00244	CcSEcCtD
Terbutaline—BCHE—Peptide hormone metabolism—PCSK1—pancreatic cancer	0.000601	0.027	CbGpPWpGaD
Terbutaline—Vomiting—Epirubicin—pancreatic cancer	0.000579	0.00235	CcSEcCtD
Terbutaline—Rash—Epirubicin—pancreatic cancer	0.000574	0.00233	CcSEcCtD
Terbutaline—Dermatitis—Epirubicin—pancreatic cancer	0.000574	0.00233	CcSEcCtD
Terbutaline—Headache—Epirubicin—pancreatic cancer	0.00057	0.00231	CcSEcCtD
Terbutaline—ADRB2—Arf6 signaling events—AGTR1—pancreatic cancer	0.000562	0.0252	CbGpPWpGaD
Terbutaline—Dizziness—Doxorubicin—pancreatic cancer	0.000557	0.00226	CcSEcCtD
Terbutaline—Nausea—Epirubicin—pancreatic cancer	0.000541	0.00219	CcSEcCtD
Terbutaline—ADRB2—GPCRs, Other—SSTR2—pancreatic cancer	0.000541	0.0243	CbGpPWpGaD
Terbutaline—Vomiting—Doxorubicin—pancreatic cancer	0.000536	0.00217	CcSEcCtD
Terbutaline—Rash—Doxorubicin—pancreatic cancer	0.000531	0.00215	CcSEcCtD
Terbutaline—Dermatitis—Doxorubicin—pancreatic cancer	0.000531	0.00215	CcSEcCtD
Terbutaline—Headache—Doxorubicin—pancreatic cancer	0.000528	0.00214	CcSEcCtD
Terbutaline—ADRB2—GPCRs, Other—CCKBR—pancreatic cancer	0.000522	0.0235	CbGpPWpGaD
Terbutaline—Nausea—Doxorubicin—pancreatic cancer	0.0005	0.00203	CcSEcCtD
Terbutaline—ADRB2—Arf6 trafficking events—AGTR1—pancreatic cancer	0.000444	0.0199	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 signaling events—MET—pancreatic cancer	0.000372	0.0167	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 signaling events—EGF—pancreatic cancer	0.000346	0.0155	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—SCT—pancreatic cancer	0.000332	0.0149	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—GCG—pancreatic cancer	0.000316	0.0142	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—GLP1R—pancreatic cancer	0.000309	0.0139	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—PRLHR—pancreatic cancer	0.000299	0.0134	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Other—CNR1—pancreatic cancer	0.000284	0.0128	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—IAPP—pancreatic cancer	0.000274	0.0123	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—PTHLH—pancreatic cancer	0.000263	0.0118	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—PRLHR—pancreatic cancer	0.000257	0.0115	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—SSTR3—pancreatic cancer	0.000255	0.0114	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 trafficking events—CDH1—pancreatic cancer	0.000254	0.0114	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.000244	0.011	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.000235	0.0106	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.000227	0.0102	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.000218	0.0098	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 signaling events—SRC—pancreatic cancer	0.000215	0.00965	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—GCG—pancreatic cancer	0.000214	0.00962	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.000209	0.00939	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.000205	0.00921	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.000201	0.00904	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PRLHR—pancreatic cancer	0.000195	0.00877	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.000194	0.00873	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 signaling events—EGFR—pancreatic cancer	0.000188	0.00846	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 trafficking events—CTNNB1—pancreatic cancer	0.000188	0.00843	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—FUT8—pancreatic cancer	0.000186	0.00834	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.000172	0.00772	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.000169	0.0076	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—SSTR3—pancreatic cancer	0.000166	0.00746	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—SSTR1—pancreatic cancer	0.000159	0.00715	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PPY—pancreatic cancer	0.000156	0.00701	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—SSTR2—pancreatic cancer	0.000153	0.00689	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.000151	0.00679	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCKBR—pancreatic cancer	0.000148	0.00665	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.000147	0.00662	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.000145	0.00651	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.000127	0.00572	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CG—pancreatic cancer	0.000127	0.00571	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.000123	0.00554	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—SCT—pancreatic cancer	0.000121	0.00542	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCK—pancreatic cancer	0.000115	0.00517	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.000115	0.00515	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.000114	0.00511	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—PCSK1—pancreatic cancer	0.000113	0.00509	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CNR2—pancreatic cancer	0.000112	0.00504	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GLP1R—pancreatic cancer	0.000112	0.00504	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CD—pancreatic cancer	0.000112	0.00502	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCKAR—pancreatic cancer	0.00011	0.00496	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000106	0.00475	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000104	0.00466	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—SHH—pancreatic cancer	0.000101	0.00452	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PRLHR—pancreatic cancer	0.0001	0.0045	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—IAPP—pancreatic cancer	9.94e-05	0.00446	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	9.74e-05	0.00438	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CB—pancreatic cancer	9.74e-05	0.00438	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PTCH1—pancreatic cancer	9.54e-05	0.00429	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PTHLH—pancreatic cancer	9.54e-05	0.00429	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—SSTR3—pancreatic cancer	9.39e-05	0.00422	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GDI1—pancreatic cancer	9.19e-05	0.00413	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GDI2—pancreatic cancer	9.19e-05	0.00413	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—SSTR1—pancreatic cancer	9e-05	0.00404	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PPY—pancreatic cancer	8.83e-05	0.00396	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—SST—pancreatic cancer	8.73e-05	0.00392	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—SSTR2—pancreatic cancer	8.66e-05	0.00389	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—SSTR3—pancreatic cancer	8.52e-05	0.00383	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PTEN—pancreatic cancer	8.42e-05	0.00378	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CCKBR—pancreatic cancer	8.37e-05	0.00376	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—SSTR1—pancreatic cancer	8.17e-05	0.00367	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CNR1—pancreatic cancer	8.05e-05	0.00362	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PPY—pancreatic cancer	8.01e-05	0.0036	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—SSTR2—pancreatic cancer	7.87e-05	0.00353	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GCG—pancreatic cancer	7.78e-05	0.00349	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCKBR—pancreatic cancer	7.6e-05	0.00341	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—AGTR1—pancreatic cancer	7.42e-05	0.00333	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PRSS1—pancreatic cancer	7.25e-05	0.00326	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GAST—pancreatic cancer	7.19e-05	0.00323	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—SCT—pancreatic cancer	6.82e-05	0.00306	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GAST—pancreatic cancer	6.53e-05	0.00293	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CCK—pancreatic cancer	6.51e-05	0.00292	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CNR2—pancreatic cancer	6.34e-05	0.00285	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	6.34e-05	0.00285	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ARG2—pancreatic cancer	6.29e-05	0.00282	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	6.24e-05	0.0028	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—SCT—pancreatic cancer	6.19e-05	0.00278	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—GCG—pancreatic cancer	5.96e-05	0.00268	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CA—pancreatic cancer	5.94e-05	0.00267	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRLHR—pancreatic cancer	5.92e-05	0.00266	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCK—pancreatic cancer	5.91e-05	0.00265	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CNR2—pancreatic cancer	5.76e-05	0.00259	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GLP1R—pancreatic cancer	5.76e-05	0.00259	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCKAR—pancreatic cancer	5.66e-05	0.00254	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—IAPP—pancreatic cancer	5.62e-05	0.00252	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ACVR1B—pancreatic cancer	5.57e-05	0.0025	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ZNRF3—pancreatic cancer	5.57e-05	0.0025	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TYMP—pancreatic cancer	5.5e-05	0.00247	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	5.39e-05	0.00242	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—SHH—pancreatic cancer	5.16e-05	0.00232	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IAPP—pancreatic cancer	5.1e-05	0.00229	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DTX1—pancreatic cancer	5.04e-05	0.00226	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SSTR3—pancreatic cancer	5.04e-05	0.00226	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	4.93e-05	0.00221	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	4.9e-05	0.0022	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	4.9e-05	0.0022	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	4.83e-05	0.00217	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PPY—pancreatic cancer	4.73e-05	0.00213	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	4.65e-05	0.00209	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	4.55e-05	0.00204	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.54e-05	0.00204	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	4.49e-05	0.00202	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—SST—pancreatic cancer	4.48e-05	0.00201	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	4.46e-05	0.00201	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GLP1R—pancreatic cancer	4.43e-05	0.00199	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	4.39e-05	0.00197	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—DPYD—pancreatic cancer	4.36e-05	0.00196	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	4.22e-05	0.0019	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	4.22e-05	0.0019	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	4.19e-05	0.00188	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SLC2A2—pancreatic cancer	4.14e-05	0.00186	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	4.13e-05	0.00186	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	4.1e-05	0.00184	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	4.1e-05	0.00184	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.09e-05	0.00184	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	4.08e-05	0.00183	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	3.99e-05	0.00179	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	3.95e-05	0.00177	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.95e-05	0.00177	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GAST—pancreatic cancer	3.86e-05	0.00173	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	3.81e-05	0.00171	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SCT—pancreatic cancer	3.66e-05	0.00164	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	3.66e-05	0.00164	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.6e-05	0.00162	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCK—pancreatic cancer	3.49e-05	0.00157	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	3.4e-05	0.00153	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	3.4e-05	0.00153	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	3.4e-05	0.00153	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	3.35e-05	0.0015	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	3.24e-05	0.00146	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CD44—pancreatic cancer	3.2e-05	0.00144	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	3.2e-05	0.00144	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.14e-05	0.00141	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	3.13e-05	0.00141	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—HRAS—pancreatic cancer	3.13e-05	0.00141	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.11e-05	0.0014	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GCG—pancreatic cancer	3.07e-05	0.00138	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SHH—pancreatic cancer	3.05e-05	0.00137	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	3.03e-05	0.00136	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	3.01e-05	0.00135	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	2.89e-05	0.0013	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	2.89e-05	0.0013	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—STK11—pancreatic cancer	2.89e-05	0.0013	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.71e-05	0.00122	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SST—pancreatic cancer	2.65e-05	0.00119	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.61e-05	0.00117	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	2.6e-05	0.00117	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	2.59e-05	0.00116	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	2.58e-05	0.00116	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TYMS—pancreatic cancer	2.48e-05	0.00112	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	2.44e-05	0.0011	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	2.4e-05	0.00108	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.37e-05	0.00106	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GCG—pancreatic cancer	2.36e-05	0.00106	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.29e-05	0.00103	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	2.25e-05	0.00101	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STK11—pancreatic cancer	2.22e-05	0.000996	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.08e-05	0.000935	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOE—pancreatic cancer	2.02e-05	0.000907	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2e-05	0.000898	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	1.94e-05	0.000872	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.92e-05	0.000863	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.91e-05	0.000859	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HES1—pancreatic cancer	1.9e-05	0.000851	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CG—pancreatic cancer	1.82e-05	0.000819	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.82e-05	0.000815	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARG—pancreatic cancer	1.76e-05	0.00079	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	1.74e-05	0.000784	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TERT—pancreatic cancer	1.66e-05	0.000746	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CD—pancreatic cancer	1.6e-05	0.00072	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	1.59e-05	0.000714	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	1.58e-05	0.000712	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOE—pancreatic cancer	1.55e-05	0.000697	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KDR—pancreatic cancer	1.52e-05	0.000682	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	1.45e-05	0.000649	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	1.43e-05	0.000643	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	1.4e-05	0.000629	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	1.4e-05	0.000629	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CB—pancreatic cancer	1.4e-05	0.000627	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTGS2—pancreatic cancer	1.38e-05	0.000622	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGF—pancreatic cancer	1.38e-05	0.000621	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	1.28e-05	0.000573	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	1.23e-05	0.000553	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.22e-05	0.000547	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTEN—pancreatic cancer	1.21e-05	0.000542	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	1.2e-05	0.000541	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.11e-05	0.000497	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	1.07e-05	0.000482	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	1.03e-05	0.000463	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	1.02e-05	0.00046	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	9.95e-06	0.000447	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	9.86e-06	0.000443	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	9.6e-06	0.000431	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	9.51e-06	0.000427	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	9.32e-06	0.000419	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	9.27e-06	0.000416	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	9.04e-06	0.000406	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SRC—pancreatic cancer	8.59e-06	0.000386	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CA—pancreatic cancer	8.52e-06	0.000382	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	8.37e-06	0.000376	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	8.29e-06	0.000372	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	8.27e-06	0.000371	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MYC—pancreatic cancer	7.7e-06	0.000346	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	7.68e-06	0.000345	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	7.53e-06	0.000338	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	7.12e-06	0.00032	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKT1—pancreatic cancer	6.96e-06	0.000312	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	6.54e-06	0.000294	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TP53—pancreatic cancer	6.32e-06	0.000284	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	6.05e-06	0.000272	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	5.34e-06	0.00024	CbGpPWpGaD
